SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Trading Update

26 Apr 2019 07:00

RNS Number : 1677X
Rotork PLC
26 April 2019
 

Rotork Plc

Trading update

Rotork plc ("Rotork"), the global flow control and instrumentation company, issues the following trading update covering the first quarter period from 1 January to 31 March 2019 ahead of its Annual General Meeting to be held today.

The first quarter saw a gradual improvement in overall levels of activity from the fourth quarter. Order intake (on an organic constant currency basis, "OCC") was modestly ahead of the fourth quarter, though as anticipated was down on the 2018 comparator period which included several large greenfield orders, principally from the Downstream Oil & Gas end user market. 

Our Growth Acceleration Programme continues on track with progress across all four pillars. Our lean/continuous improvement rollout has started encouragingly. Our phased transition to a market segment orientation commences in the second quarter with China, Japan and South Korea. 

Rotork continues to be highly cash generative with a strong balance sheet and net cash of £46.5m at 31 March 2019 (£43.6m at 31 December 2018).

Whilst we remain mindful of macroeconomic uncertainty we continue to expect to deliver modest sales growth on an OCC basis in 2019, with lower year on year sales in the first half reflecting the strong comparator period, and full year margins to show progress on 2018.

Rotork will publish 2019 half-year results on Tuesday 6 August 2019.

 

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The figures quoted in this announcement are unaudited and are subject to the review process that will be undertaken for the H1 19 results announcement. The person responsible for arranging for the release of this announcement on behalf of Rotork is Helen Barrett-Hague (Company Secretary).

 

Notes

1. OCC (organic constant currency) growth rates restate 2019 at 2018 exchange rates and remove the contributions from disposals made in 2018.

2. This announcement contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement, and Rotork undertakes no obligation to update these forward-looking statements. Nothing in this Trading Statement should be construed as a profit forecast.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFVTSVIEFIA
Date   Source Headline
11th Jun 202612:08 pmRNSDirector/PDMR Shareholding
1st Jun 20269:34 amRNSTotal Voting Rights
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20265:57 pmRNSDirector/PDMR Shareholding
12th May 202612:25 pmRNSDirector/PDMR Shareholding
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:45 amRNSResult of AGM
1st May 20269:53 amRNSTotal Voting Rights
1st May 20267:00 amRNSTrading update
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202610:49 amRNSDirector/PDMR Shareholding
21st Apr 20264:58 pmRNSHolding(s) in Company
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:18 pmRNSDirector/PDMR Shareholding
15th Apr 20261:19 pmRNSShare buyback programme
13th Apr 20264:37 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20268:52 amRNSDirector/PDMR Shareholding
7th Apr 20269:52 amRNSTransaction in Own Shares - Clarification Notice
7th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20269:10 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20263:03 pmRNS2025 Annual Report and Notice of 2026 AGM
26th Mar 20261:55 pmRNSDirector/PDMR Shareholding
25th Mar 202611:36 amRNSDirector/PDMR Shareholding
23rd Mar 20262:38 pmRNSHolding(s) in Company
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:01 amRNSDirector/PDMR Shareholding
13th Mar 20261:54 pmRNSShare buyback programme
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 20264:00 pmRNSHolding(s) in Company
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
11th Mar 202612:16 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 full year results
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:16 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.